DekaBank Deutsche Girozentrale has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities portfolio as of the close of business on September 30, 2026. The filing was submitted on October 27, 2026, and lists the firm's holdings across a broad range of industries.
The report identifies Stefan Frauendorf as the Assistant Vice President responsible for the filing, which was filed under Control Number 028-13421. The filing details the firm's holdings in over 100 distinct companies, including major technology, healthcare, and industrial firms.
Key positions disclosed in the filing include significant holdings in Apple Inc., with 9,902,183 shares reported as Class 1 and 1,681,671 shares as Class 2. Alphabet Inc. is also a major holding, with Class A shares totaling 8,841,901 and Class C shares totaling 1,702,229. Amazon.com Inc. is listed with 10,206,311 Class 1 shares and 3,689,138 Class 2 shares.
Other notable positions include Applied Materials Inc., with 1,008,045 Class 1 shares and 567,466 Class 2 shares; Abbott Laboratories, with 3,489,986 Class 1 shares and 546,138 Class 2 shares; and AbbVie Inc., with 2,788,614 Class 1 shares and 545,246 Class 2 shares.
The filing also lists a diverse array of other holdings, ranging from financial services like American Express and Allstate to industrial companies such as 3M Company and American Tower Corporation. Additionally, the filing includes positions in pharmaceutical companies like Amgen and Amplitude Inc., as well as energy and utility firms like AES Corp. and Atmos Energy Corp.
